Come check out one of Integra Connect PrecisionQ’s poster presentations at ESMO at the Messe Berlin in Berlin, Germany today, Monday, October 20, 2025, from 12:00-12:45 CEST. This poster presents: Real-World Study on ESR1 Positivity Rate in Correlation to Length of Exposure on Endocrine Therapy +/- CDK4/6i The findings on this study demonstrate that patient duration of exposure to endocrine therapy increases the likelihood of acquiring an ESR1 mutation. Poster 521P / Abstract 2710 Link to Abstract: https://lnkd.in/eJsutDiR Authors: Michael Gart | Erin Alwon | Ashley Lamb | Kristen Henn | Prateesh Varughese PharmD MBA | Brandon Wang | Lisa M. | Robert Geller | Jeffrey Scott
